References
- Kroker M. Overview of current therapies in diabetes mellitus. EDTNA ERCA J 2004; 30(3): 124–7.
- Loh KC, Leow MK. Current therapeutic strategies for type 2 diabetes mellitus. Annals of the Academy of Medicine Singapore 2002; 31(6): 722–9.
- Zimmet P, Collier G. Clinical efficacy of metformin against insulin resistance parameters. Drugs 1999; 58(Suppl.1): 21–8.
- United Kingdom Prospective Diabetes Study (UKPDS) Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22: 1125–36.
- Couper JJ, Prins JB. Recent advances in therapy of diabetes. MJA 2003; 179: 441–7.
- Skyler JS. New diabetes criteria and clinical implications. Drugs 1999; 58(Suppl 1): 1–2.
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up Report on the Diagnosis of Diabetes Mellitus. Clinical Diabetes 2004; 22: 71–9.
- Szybinski Z. Hyperglycaemic spikes as a risk factor of diabetic complications. Przegl Lek 2006: 63(Suppl 4): 1–2.
- Hosszuacute;falusi N, Pánczél P, Jánoskuti L. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men—Helsinki Policemen Study. Circulation 1999; 100: 118.
- Donahue RP, Abbott RD, Reed DM, et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance—Honolulu Heart Program. The Journal of American Medical Association 2004; 291: 1857–63.
- Bohannon NJV. Coronary artery disease and diabetes—secondary prevention needs more attention. Postgraduate Medicine 1999; 105(2): 50.
- Ceriello A, Davidson J, Hanefield M, et al. International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006: 16(7): 453–6.
- Bell DS. Importance of postprandial glucose control. South Med J 2001; 94 (8): 804–9.
- Ceriello A. Postprandial glucose regulation and diabetic complications. Archives of Internal Medicine 2004; 164(19): 2090–5.
- Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. American Family Physician 1998; 58 (6): 1360–5.
- Hermann LS. Optimizing therapy for insulin treated type 2 diabetes mellitus. Drugs and Aging 2000; 17(4): 283–94.
- Cooppan R. The changing model of insulin use in type 2 diabetes: techniques, tactic for getting to goal. Postgraduate Medicine 2003; 113(6): 59–64.
- Bilo HJ. Absorption kinetics and action profile of intermediate acting human insulins. Diabetes Research 1987; 4(1): 39–43.
- Schrot RJ. Targeting plasma glucose: preprandial versus postprandial. Clinical Diabetes 2004; 22: 169–72.